Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Non-randomized Study on the Management of Operable T1-N0 or T2-N0 Oral Cavity and Oropharynx Cancer and Sentinel Lymph Node in Outpatient Surgery

NCT03545256 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT03545256
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03545256 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Non-randomized Study on the Management of Operable T1-N0 or T2-N0 Oral Cavity and Oropharynx Cancer and Sentinel Lymph Node in Outpatient Surgery
Lead sponsor
University Hospital, Montpellier
Phase
Not applicable
Overall status
Recruiting
Start date
May 31, 2018
Completion date
July 1, 2026
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer t1-n0 or t2-n0 of the oral cavity